Susan E. Burwig, Executive Vice President of Operations at Medpace Holdings, Inc., filed a Form 4 on October 23, 2026, reporting the exercise of employee stock options and an acquisition of common stock on October 21, 2026.

Key Highlights

  • Reporting person: Susan E. Burwig, identified in the filing as Exec. VP, Operations of Medpace Holdings, Inc. (NASDAQ:MEDP).
  • Option exercise: Burwig exercised an employee stock option (transaction code M) covering 2,700 shares of common stock on October 21, 2026, at a conversion/exercise price of $166.73.
  • Shares acquired: 2,700 shares of common stock were acquired (code A) at $166.73 per share.
  • Post-transaction ownership: Following the reported transaction, Burwig directly beneficially owned 73,684 shares of common stock.
  • Remaining derivative securities: 328 employee stock options remained beneficially owned directly following the transaction.
  • Option vesting: According to the filing, "The option vested in full on October 27, 2025."
  • Signing: The form was signed by Stephen P. Ewald as Attorney-in-Fact for Susan E. Burwig, dated October 23, 2026.

Burwig's Option Exercise and Resulting Ownership at Medpace Holdings

According to the filing, Susan E. Burwig, serving as Executive Vice President of Operations at Medpace Holdings, Inc. (NASDAQ:MEDP), reported a single transaction dated October 21, 2026. The transaction involved the exercise of an employee stock option with a stated exercise price of $166.73 per share, covering 2,700 shares of common stock. The transaction is recorded under code M, indicating the exercise or conversion of a derivative security.

The filing discloses that the underlying employee stock option had an expiration date of October 27, 2026, and that, per the explanation of responses, "The option vested in full on October 27, 2025." The price of the derivative security is listed as $0. As a result of the exercise, 2,700 shares of common stock were acquired directly. Following the reported transaction, Burwig's direct beneficial ownership of common stock stood at 73,684 shares, according to the filing.

In Table II, the filing further indicates that after the exercise of the 2,700-option position, 328 employee stock options remained directly beneficially owned by Burwig. The form was filed on October 23, 2026, and was executed by Stephen P. Ewald as Attorney-in-Fact for Susan E. Burwig. No indirect ownership positions were reported.

What Was Disclosed

The Form 4 filed October 23, 2026, discloses that Medpace Holdings Executive VP Susan E. Burwig exercised 2,700 employee stock options at $166.73 on October 21, 2026, resulting in direct beneficial ownership of 73,684 shares of common stock and 328 remaining options.